Global Modified Release Coatings Market : Industry Analysis and Forecast (2020-2027)-By Polymer Type, Substrate Type, Type,and Region.


Global Modified Release Coatings Market was valued US$ XX.50 Bn and is expected to reach XX.46 Bn by 2027, at a CAGR of 7.23% during the forecast period.

Global Modified Release Coatings Market

To know about the Research Methodology :- Request Free Sample Report

Demand for the effective coating across the globe and huge growth in the pharmaceutical industries are considered as supportive market for the market growth; roughly 40 to 45% of market share is acquired by tablet coating sector.

Global Modified Release Coatings Market Definition:

Modified release coating isdefined as an advanced technology in the pharmaceutical coating sector in order to modify the action of active drug when released and engrossed into the body. Coating can be applied directly on the substrate or else by providing coating to the small capsules before compression process.

The report study has analyzed the revenue impact of COVID-19 pandemic on the sales revenue of market leaders, market followers, and disrupters in the report, and the same is reflected in our analysis.

Global Modified Release Coatings Market Drivers and Restraints:

Technological advancement and development in method of manufacturing process in developed and developing countries are driving the growth of modified release coatings market globally. Modified Release Coatings have broad application in the coating of tablet, capsules, pill expected to increase the market demand in near future. Machinery manufacturing process and increasing disposable income, rapid urbanization and established healthcare sector have managed to increase modified released related product amongst the growing population and is is estimated to boost up the modified release coatingsmarket.

Similarly,healthy evolution of the polymeric sector is also assessed to drive the modified release coatingsmarket. Also, availability of type as per patient suitability such as sustain release and enteric coating to provide targeted drug delivery application for the treatment of saviour diseases expected to record noticeable growth, huge growth in the paediatric and geriatric patients where modified release processis broadly utilised and covering market value with significant growth of US$ XX Bn. In terms of market share Asia Pacific was valued US$ XX Bn with considerable CAGR of XX%. Major key vendors are investing in modified release coatings market as this market is expected to show constant growth.

Additionally, upsurge in the request for the microencapsulated biomolecules is growing in the pharmaceutical industry owing to the huge requirement for targeted drug delivery system. Hence, the expansionin the drugs required for these applications are estimated to lift the request for modified release coatings for effective and targeted delivery of API. These are widelyused by pharmaceutical companies tocover the unpleasant taste andodour of drugs
However, limitations of raw materials and highmanufacturingcost negatively influence the modified release coatings market growth.

Global Modified Release Coatings Market Segment analysis:

By type segment, sustainedmodified coating sub segment is expected to dominate the modified release coatings market during the forecast years. Available large chain for the business will require high amount of modified release coatings, is expected to help the market growth. Furthermore, existing verity of mode of administration like in vitro and in vivo methods has promotedtargeted market growth.

The newer, high-growth substrate of sustained modified coatings such as capsule, pills and tablets. On the other hand, huge growth in the demand for the tablet which is showing constant support owing to ease of application and introduction of new API in the pharmaceutical drug applications.The targeted segment market is likely to be valued at approximately US$ X.4 Bn in 2019, owing to the increasing consumer demand, Virtually, 45% of market is acquired by sustained modifies segment.

Global Modified Release Coatings Market Regional Analysis:

Regionally, APAC is expected to dominate the modified release coatings market with an expected CAGR of XX % during the forecast period. Advancement in machinery in Asia Pacific region is boosting the market growth, especially India and Chinaare documented as major contributors. In 2019 market size was valued US$ XX Bn while in India market size was valued US$ XX Bn and expected to increase by US$ XX Bn in coming years.In 2019, approximately 40% of market is acquired by Asia Pacific region and expected to grow constantly in future.

Asia Pacific is followed by North America. North America is forecasted to show good growth owing to expandingawareness in microencapsulated tablets, and pills considered as major driving factor with advanced healthcare industry present in the region.

The objective of the report is to present a comprehensive analysis of theGlobalModified Release Coatings Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Modified Release Coatings Market dynamics, structure by analysing the market segments and project the Global Modified Release Coatings Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Modified Release Coatings Market make the report investor’s guide.

Scope of Modified Release Coatings Market: Inquire before buying


Global Modified Release Coatings Market, By Polymer Type

• Polyvinyl & Cellulose Acetate
• Polyethylene Glycol (PEG)
• Ethyl & Methyl Cellulose
• Methacrylic Acid
• Others

Global Modified Release Coatings Market, By Substrate Type

• Tablets
• Capsules
• Pills

Global Modified Release Coatings Market, ByType

• Sustained Modified Coatings
• Enteric Coatings

Global Modified Release Coatings Market, By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players Operating the Modified Release Coatings Market,

• Teva Pharmaceutical Industries Ltd
• Valeant Pharmaceuticals International, Inc
• Sun Pharmaceutical Industries Ltd
• Evonik Industries AG
• Coating Place, Inc
• GlaxoSmithKline plc
• Corium International, Inc
• Orbis Biosciences, Inc
• Mylan N.V
• Pfizer, Inc
• Evonik
• Colorcon
• BASF SE
• Novartis AG
• AstraZeneca
• Depomed, Inc 





Global Modified Release Coatings Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Metal Surface Treatment Chemical Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators

6. Global Modified Release Coatings Market Analysis and Forecast
6.1. Modified Release Coatings Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Modified Release Coatings Analysis and Forecast, By Polymer Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Modified Release Coatings Value Share Analysis, By Polymer Type
7.4. Modified Release Coatings Size (US$ Bn) Forecast, By Polymer Type
7.5. Modified Release Coatings Analysis, By Polymer Type
7.6. Modified Release Coatings Attractiveness Analysis, By Polymer Type

8. Global Modified Release Coatings Analysis and Forecast, By Substrate Type
8.1. Introduction and Definition
8.2. Key Findings
8.3. Modified Release Coatings Value Share Analysis, By Substrate Type
8.4. Modified Release Coatings Size (US$ Bn) Forecast, By Substrate Type
8.5. Modified Release Coatings Analysis, By Substrate Type
8.6. Modified Release Coatings Attractiveness Analysis, By Substrate Type

9. Global Modified Release Coatings Analysis and Forecast, By Type
9.1. Introduction and Definition
9.2. Key Findings
9.3. Modified Release Coatings Value Share Analysis, By Type
9.4. Modified Release Coatings Size (US$ Bn) Forecast, By Type
9.5. Modified Release Coatings Analysis, By Type
9.6. Modified Release Coatings Attractiveness Analysis, By Type

10. Global Modified Release Coatings Analysis, by Region
10.1. Modified Release Coatings Value Share Analysis, by Region
10.2. Modified Release Coatings Size (US$ Bn) Forecast, by Region
10.3. Modified Release Coatings Attractiveness Analysis, by Region

11. North America Modified Release Coatings Analysis
11.1. Key Findings
11.2. North America Modified Release Coatings Overview
11.3. North America Modified Release Coatings Value Share Analysis, By Polymer Type
11.4. North America Modified Release Coatings Forecast, By Polymer Type
11.4.1. Polyvinyl & Cellulose Acetate
11.4.2. Polyethylene Glycol (PEG)
11.4.3. Ethyl & Methyl Cellulose
11.4.4. Methacrylic Acid
11.4.5. Others
11.5. North America Modified Release Coatings Value Share Analysis, By Substrate Type
11.6. North America Modified Release Coatings Forecast, By Substrate Type
11.6.1. Tablets
11.6.2. Capsules
11.6.3. Pills
11.7. North America Modified Release Coatings Value Share Analysis, By Type
11.8. North America Modified Release Coatings Forecast, By Type
11.8.1. Sustained Modified Coatings
11.8.2. Enteric Coatings
11.9. North America Modified Release Coatings Value Share Analysis, by Country
11.10. North America Modified Release Coatings Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Modified Release Coatings Analysis, by Country
11.12. U.S. Modified Release Coatings Forecast, By Polymer Type
11.12.1. Polyvinyl & Cellulose Acetate
11.12.2. Polyethylene Glycol (PEG)
11.12.3. Ethyl & Methyl Cellulose
11.12.4. Methacrylic Acid
11.12.5. Others
11.13. U.S. Modified Release Coatings Forecast, By Substrate Type
11.13.1. Tablets
11.13.2. Capsules
11.13.3. Pills
11.14. U.S. Modified Release Coatings Forecast, By Type
11.14.1. Sustained Modified Coatings
11.14.2. Enteric Coatings
11.15. Canada Modified Release Coatings Forecast, By Polymer Type
11.15.1. Polyvinyl & Cellulose Acetate
11.15.2. Polyethylene Glycol (PEG)
11.15.3. Ethyl & Methyl Cellulose
11.15.4. Methacrylic Acid
11.15.5. Others
11.16. Canada Modified Release Coatings Forecast, By Substrate Type
11.16.1. Tablets
11.16.2. Capsules
11.16.3. Pills
11.17. Canada Modified Release Coatings Forecast, By Type
11.17.1. Sustained Modified Coatings
11.17.2. Enteric Coatings
11.18. North America Modified Release Coatings Attractiveness Analysis
11.18.1. By Polymer Type
11.18.2. By Substrate Type
11.18.3. By Type
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments

12. Europe Modified Release Coatings Analysis
12.1. Key Findings
12.2. Europe Modified Release Coatings Overview
12.3. Europe Modified Release Coatings Value Share Analysis, By Polymer Type
12.4. Europe Modified Release Coatings Forecast, By Polymer Type
12.4.1. Polyvinyl & Cellulose Acetate
12.4.2. Polyethylene Glycol (PEG)
12.4.3. Ethyl & Methyl Cellulose
12.4.4. Methacrylic Acid
12.4.5. Others
12.5. Europe Modified Release Coatings Value Share Analysis, By Substrate Type
12.6. Europe Modified Release Coatings Forecast, By Substrate Type
12.6.1. Tablets
12.6.2. Capsules
12.6.3. Pills
12.7. Europe Modified Release Coatings Value Share Analysis, By Type
12.8. Europe Modified Release Coatings Forecast, By Type
12.8.1. Sustained Modified Coatings
12.8.2. Enteric Coatings
12.9. Europe Modified Release Coatings Value Share Analysis, by Country
12.10. Europe Modified Release Coatings Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Norway
12.10.7. Russia
12.10.8. Rest of Europe
12.11. Europe Modified Release Coatings Analysis, by Country
12.12. Germany Modified Release Coatings Forecast, By Polymer Type
12.12.1. Polyvinyl & Cellulose Acetate
12.12.2. Polyethylene Glycol (PEG)
12.12.3. Ethyl & Methyl Cellulose
12.12.4. Methacrylic Acid
12.12.5. Others
12.13. Germany Modified Release Coatings Forecast, By Substrate Type
12.13.1. Tablets
12.13.2. Capsules
12.13.3. Pills
12.14. Germany Modified Release Coatings Forecast, By Type
12.14.1. Sustained Modified Coatings
12.14.2. Enteric Coatings
12.15. U.K. Modified Release Coatings Forecast, By Polymer Type
12.15.1. Polyvinyl & Cellulose Acetate
12.15.2. Polyethylene Glycol (PEG)
12.15.3. Ethyl & Methyl Cellulose
12.15.4. Methacrylic Acid
12.15.5. Others
12.16. U.K. Modified Release Coatings Forecast, By Substrate Type
12.16.1. Tablets
12.16.2. Capsules
12.16.3. Pills
12.17. U.K. Modified Release Coatings Forecast, By Type
12.17.1. Sustained Modified Coatings
12.17.2. Enteric Coatings
12.18. France Modified Release Coatings Forecast, By Polymer Type
12.18.1. Polyvinyl & Cellulose Acetate
12.18.2. Polyethylene Glycol (PEG)
12.18.3. Ethyl & Methyl Cellulose
12.18.4. Methacrylic Acid
12.18.5. Others
12.19. France Modified Release Coatings Forecast, By Substrate Type
12.19.1. Tablets
12.19.2. Capsules
12.19.3. Pills
12.20. France Modified Release Coatings Forecast, By Type
12.20.1. Sustained Modified Coatings
12.20.2. Enteric Coatings
12.21. Italy Modified Release Coatings Forecast, By Polymer Type
12.21.1. Polyvinyl & Cellulose Acetate
12.21.2. Polyethylene Glycol (PEG)
12.21.3. Ethyl & Methyl Cellulose
12.21.4. Methacrylic Acid
12.21.5. Others
12.22. Italy Modified Release Coatings Forecast, By Substrate Type
12.22.1. Tablets
12.22.2. Capsules
12.22.3. Pills
12.23. Italy Modified Release Coatings Forecast, By Type
12.23.1. Sustained Modified Coatings
12.23.2. Enteric Coatings
12.24. Spain Modified Release Coatings Forecast, By Polymer Type
12.24.1. Polyvinyl & Cellulose Acetate
12.24.2. Polyethylene Glycol (PEG)
12.24.3. Ethyl & Methyl Cellulose
12.24.4. Methacrylic Acid
12.24.5. Others
12.25. Spain Modified Release Coatings Forecast, By Substrate Type
12.25.1. Tablets
12.25.2. Capsules
12.25.3. Pills
12.26. Spain Modified Release Coatings Forecast, By Type
12.26.1. Sustained Modified Coatings
12.26.2. Enteric Coatings
12.27. NorwayModified Release Coatings Forecast, By Polymer Type
12.27.1. Polyvinyl & Cellulose Acetate
12.27.2. Polyethylene Glycol (PEG)
12.27.3. Ethyl & Methyl Cellulose
12.27.4. Methacrylic Acid
12.27.5. Others
12.28. Norway Modified Release Coatings Forecast, By Substrate Type
12.28.1. Tablets
12.28.2. Capsules
12.28.3. Pills
12.29. Norway Modified Release Coatings Forecast, By Type
12.29.1. Sustained Modified Coatings
12.29.2. Enteric Coatings
12.30. RussiaModified Release Coatings Forecast, By Polymer Type
12.30.1. Polyvinyl & Cellulose Acetate
12.30.2. Polyethylene Glycol (PEG)
12.30.3. Ethyl & Methyl Cellulose
12.30.4. Methacrylic Acid
12.30.5. Others
12.31. Russia Modified Release Coatings Forecast, By Substrate Type
12.31.1. Tablets
12.31.2. Capsules
12.31.3. Pills
12.32. Russia Modified Release Coatings Forecast, By Type
12.32.1. Sustained Modified Coatings
12.32.2. Enteric Coatings
12.33. Rest of Europe Modified Release Coatings Forecast, By Polymer Type
12.33.1. Polyvinyl & Cellulose Acetate
12.33.2. Polyethylene Glycol (PEG)
12.33.3. Ethyl & Methyl Cellulose
12.33.4. Methacrylic Acid
12.33.5. Others
12.34. Rest of Europe Modified Release Coatings Forecast, By Substrate Type
12.34.1. Tablets
12.34.2. Capsules
12.34.3. Pills
12.35. Rest of Europe Modified Release Coatings Forecast, By Type
12.35.1. Sustained Modified Coatings
12.35.2. Enteric Coatings
12.36. Europe Modified Release Coatings Attractiveness Analysis
12.36.1. By Polymer Type
12.36.2. By Substrate Type
12.36.3. By Type
12.37. PEST Analysis
12.38. Key Trends
12.39. Key Developments

13. Asia Pacific Modified Release Coatings Analysis
13.1. Key Findings
13.2. Asia Pacific Modified Release Coatings Overview
13.3. Asia Pacific Modified Release Coatings Value Share Analysis, By Polymer Type
13.4. Asia Pacific Modified Release Coatings Forecast, By Polymer Type
13.4.1. Polyvinyl & Cellulose Acetate
13.4.2. Polyethylene Glycol (PEG)
13.4.3. Ethyl & Methyl Cellulose
13.4.4. Methacrylic Acid
13.4.5. Others
13.5. Asia Pacific Modified Release Coatings Value Share Analysis, By Substrate Type
13.6. Asia Pacific Modified Release Coatings Forecast, By Substrate Type
13.6.1. Tablets
13.6.2. Capsules
13.6.3. Pills
13.7. Asia Pacific Modified Release Coatings Value Share Analysis, By Type
13.8. Asia Pacific Modified Release Coatings Forecast, By Type
13.8.1. Sustained Modified Coatings
13.8.2. Enteric Coatings
13.9. Asia Pacific Modified Release Coatings Value Share Analysis, by Country
13.10. Asia Pacific Modified Release Coatings Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. South Korea
13.10.5. Australia
13.10.6. Malaysia
13.10.7. Indonesia
13.10.8. Rest of Asia Pacific
13.11. Asia Pacific Modified Release Coatings Analysis, by Country
13.12. China Modified Release Coatings Forecast, By Polymer Type
13.12.1. Polyvinyl & Cellulose Acetate
13.12.2. Polyethylene Glycol (PEG)
13.12.3. Ethyl & Methyl Cellulose
13.12.4. Methacrylic Acid
13.12.5. Others
13.13. China Modified Release Coatings Forecast, By Substrate Type
13.13.1. Tablets
13.13.2. Capsules
13.13.3. Pills
13.14. China Modified Release Coatings Forecast, By Type
13.14.1. Sustained Modified Coatings
13.14.2. Enteric Coatings
13.15. India Modified Release Coatings Forecast, By Polymer Type
13.15.1. Polyvinyl & Cellulose Acetate
13.15.2. Polyethylene Glycol (PEG)
13.15.3. Ethyl & Methyl Cellulose
13.15.4. Methacrylic Acid
13.15.5. Others
13.16. India Modified Release Coatings Forecast, By Substrate Type
13.16.1. Tablets
13.16.2. Capsules
13.16.3. Pills
13.17. India Modified Release Coatings Forecast, By Type
13.17.1. Sustained Modified Coatings
13.17.2. Enteric Coatings
13.18. Japan Modified Release Coatings Forecast, By Polymer Type
13.18.1. Polyvinyl & Cellulose Acetate
13.18.2. Polyethylene Glycol (PEG)
13.18.3. Ethyl & Methyl Cellulose
13.18.4. Methacrylic Acid
13.18.5. Others
13.19. Japan Modified Release Coatings Forecast, By Substrate Type
13.19.1. Tablets
13.19.2. Capsules
13.19.3. Pills
13.20. Japan Modified Release Coatings Forecast, By Type
13.20.1. Sustained Modified Coatings
13.20.2. Enteric Coatings
13.21. South KoreaModified Release Coatings Forecast, By Polymer Type
13.21.1. Polyvinyl & Cellulose Acetate
13.21.2. Polyethylene Glycol (PEG)
13.21.3. Ethyl & Methyl Cellulose
13.21.4. Methacrylic Acid
13.21.5. Others
13.22. South Korea Modified Release Coatings Forecast, By Substrate Type
13.22.1. Tablets
13.22.2. Capsules
13.22.3. Pills
13.23. South Korea Modified Release Coatings Forecast, By Type
13.23.1. Sustained Modified Coatings
13.23.2. Enteric Coatings
13.24. AustraliaModified Release Coatings Forecast, By Polymer Type
13.24.1. Polyvinyl & Cellulose Acetate
13.24.2. Polyethylene Glycol (PEG)
13.24.3. Ethyl & Methyl Cellulose
13.24.4. Methacrylic Acid
13.24.5. Others
13.25. Australia Modified Release Coatings Forecast, By Substrate Type
13.25.1. Tablets
13.25.2. Capsules
13.25.3. Pills
13.26. Australia Modified Release Coatings Forecast, By Type
13.26.1. Sustained Modified Coatings
13.26.2. Enteric Coatings
13.27. MalaysiaModified Release Coatings Forecast, By Polymer Type
13.27.1. Polyvinyl & Cellulose Acetate
13.27.2. Polyethylene Glycol (PEG)
13.27.3. Ethyl & Methyl Cellulose
13.27.4. Methacrylic Acid
13.27.5. Others
13.28. Malaysia Modified Release Coatings Forecast, By Substrate Type
13.28.1. Tablets
13.28.2. Capsules
13.28.3. Pills
13.29. Malaysia Modified Release Coatings Forecast, By Type
13.29.1. Sustained Modified Coatings
13.29.2. Enteric Coatings
13.30. IndonesiaModified Release Coatings Forecast, By Polymer Type
13.30.1. Polyvinyl & Cellulose Acetate
13.30.2. Polyethylene Glycol (PEG)
13.30.3. Ethyl & Methyl Cellulose
13.30.4. Methacrylic Acid
13.30.5. Others
13.31. Indonesia Modified Release Coatings Forecast, By Substrate Type
13.31.1. Tablets
13.31.2. Capsules
13.31.3. Pills s
13.32. Indonesia Modified Release Coatings Forecast, By Type
13.32.1. Sustained Modified Coatings
13.32.2. Enteric Coatings
13.33. Rest of Asia Pacific Modified Release Coatings Forecast, By Substrate Type
13.33.1. Tablets
13.33.2. Capsules
13.33.3. Pills
13.34. Rest of Asia Pacific Modified Release Coatings Forecast, By Type
13.34.1. Sustained Modified Coatings
13.34.2. Enteric Coatings
13.35. Asia Pacific Modified Release Coatings Attractiveness Analysis
13.35.1. By Polymer Type
13.35.2. By Substrate Type
13.35.3. By Type
13.36. PEST Analysis
13.37. Key Trends
13.38. Key Developments

14. Middle East & Africa Modified Release Coatings Analysis
14.1. Key Findings
14.2. Middle East & Africa Modified Release Coatings Overview
14.3. Middle East & Africa Modified Release Coatings Value Share Analysis, By Polymer Type
14.4. Middle East & Africa Modified Release Coatings Forecast, By Polymer Type
14.4.1. Polyvinyl & Cellulose Acetate
14.4.2. Polyethylene Glycol (PEG)
14.4.3. Ethyl & Methyl Cellulose
14.4.4. Methacrylic Acid
14.4.5. Others
14.5. Middle East & Africa Modified Release Coatings Value Share Analysis, By Substrate Type
14.6. Middle East & Africa Modified Release Coatings Forecast, By Substrate Type
14.6.1. Tablets
14.6.2. Capsules
14.6.3. Pills
14.7. Middle East & Africa Modified Release Coatings Value Share Analysis, By Type
14.8. Middle East & Africa Modified Release Coatings Forecast, By Type
14.8.1. Sustained Modified Coatings
14.8.2. Enteric Coatings
14.9. Middle East & Africa Modified Release Coatings Value Share Analysis, by Country
14.10. Middle East & Africa Modified Release Coatings Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Modified Release Coatings Analysis, by Country
14.12. GCC Modified Release Coatings Forecast, By Polymer Type
14.12.1. Polyvinyl & Cellulose Acetate
14.12.2. Polyethylene Glycol (PEG)
14.12.3. Ethyl & Methyl Cellulose
14.12.4. Methacrylic Acid
14.12.5. Others
14.13. GCC Modified Release Coatings Forecast, By Substrate Type
14.13.1. Tablets
14.13.2. Capsules
14.13.3. Pills
14.14. GCC Modified Release Coatings Forecast, By Type
14.14.1. Sustained Modified Coatings
14.14.2. Enteric Coatings
14.15. South Africa Modified Release Coatings Forecast, By Polymer Type
14.15.1. Polyvinyl & Cellulose Acetate
14.15.2. Polyethylene Glycol (PEG)
14.15.3. Ethyl & Methyl Cellulose
14.15.4. Methacrylic Acid
14.15.5. Others
14.16. South Africa Modified Release Coatings Forecast, By Substrate Type
14.16.1. Tablets
14.16.2. Capsules
14.16.3. Pills
14.17. South Africa Modified Release Coatings Forecast, By Type
14.17.1. Sustained Modified Coatings
14.17.2. Enteric Coatings
14.18. Rest of Middle East & Africa Modified Release Coatings Forecast, By Polymer Type
14.18.1. Polyvinyl & Cellulose Acetate
14.18.2. Polyethylene Glycol (PEG)
14.18.3. Ethyl & Methyl Cellulose
14.18.4. Methacrylic Acid
14.18.5. Others
14.19. Rest of Middle East & Africa Modified Release Coatings Forecast, By Substrate Type
14.19.1. Tablets
14.19.2. Capsules
14.19.3. Pills
14.20. Rest of Middle East &Africa Modified Release Coatings Forecast, By Type
14.20.1. Sustained Modified Coatings
14.20.2. Enteric Coatings
14.21. Middle East & Africa Modified Release Coatings Attractiveness Analysis
14.21.1. By Polymer Type
14.21.2. By Substrate Type
14.21.3. By Type
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments

15. South America Modified Release Coatings Analysis
15.1. Key Findings
15.2. South America Modified Release Coatings Overview
15.3. South America Modified Release Coatings Value Share Analysis, By Polymer Type
15.4. South America Modified Release Coatings Forecast, By Polymer Type
15.4.1. Polyvinyl & Cellulose Acetate
15.4.2. Polyethylene Glycol (PEG)
15.4.3. Ethyl & Methyl Cellulose
15.4.4. Methacrylic Acid
15.4.5. Others
15.5. South America Modified Release Coatings Value Share Analysis, By Substrate Type
15.6. South America Modified Release Coatings Forecast, By Substrate Type
15.6.1. Tablets
15.6.2. Capsules
15.6.3. Pills
15.7. South America Modified Release Coatings Value Share Analysis, By Type
15.8. South America Modified Release Coatings Forecast, By Type
15.8.1. Sustained Modified Coatings
15.8.2. Enteric Coatings
15.9. South America Modified Release Coatings Value Share Analysis, by Country
15.10. South America Modified Release Coatings Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Argentina
15.10.4. Rest of South America
15.11. South America Modified Release Coatings Analysis, by Country
15.12. Brazil Modified Release Coatings Forecast, By Polymer Type
15.12.1. Polyvinyl & Cellulose Acetate
15.12.2. Polyethylene Glycol (PEG)
15.12.3. Ethyl & Methyl Cellulose
15.12.4. Methacrylic Acid
15.12.5. Others
15.13. Brazil Modified Release Coatings Forecast, By Substrate Type
15.13.1. Tablets
15.13.2. Capsules
15.13.3. Pills
15.14. Brazil Modified Release Coatings Forecast, By Type
15.14.1. Sustained Modified Coatings
15.14.2. Enteric Coatings
15.15. Mexico Modified Release Coatings Forecast, By Polymer Type
15.15.1. Polyvinyl & Cellulose Acetate
15.15.2. Polyethylene Glycol (PEG)
15.15.3. Ethyl & Methyl Cellulose
15.15.4. Methacrylic Acid
15.15.5. Others
15.16. Mexico Modified Release Coatings Forecast, By Substrate Type
15.16.1. Tablets
15.16.2. Capsules
15.16.3. Pills
15.17. Mexico Modified Release Coatings Forecast, By Type
15.17.1. Sustained Modified Coatings
15.17.2. Enteric Coatings
15.18. ArgentinaModified Release Coatings Forecast, By Polymer Type
15.18.1. Polyvinyl & Cellulose Acetate
15.18.2. Polyethylene Glycol (PEG)
15.18.3. Ethyl & Methyl Cellulose
15.18.4. Methacrylic Acid
15.18.5. Others
15.19. Argentina Modified Release Coatings Forecast, By Substrate Type
15.19.1. Tablets
15.19.2. Capsules
15.19.3. Pills
15.20. Argentina Modified Release Coatings Forecast, By Type
15.20.1. Sustained Modified Coatings
15.20.2. Enteric Coatings
15.21. Rest of South America Modified Release Coatings Forecast, By Polymer Type
15.21.1. Polyvinyl & Cellulose Acetate
15.21.2. Polyethylene Glycol (PEG)
15.21.3. Ethyl & Methyl Cellulose
15.21.4. Methacrylic Acid
15.21.5. Others
15.22. Rest of South America Modified Release Coatings Forecast, By Substrate Type
15.22.1. Tablets
15.22.2. Capsules
15.22.3. Pills
15.23. Rest of South America Modified Release Coatings Forecast, By Type
15.23.1. Sustained Modified Coatings
15.23.2. Enteric Coatings
15.24. South America Modified Release Coatings Attractiveness Analysis
15.24.1. By Polymer Type
15.24.2. By Substrate Type
15.24.3. By Type
15.25. PEST Analysis
15.26. Key Trends
15.27. Key Developments

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and BackwardIntegration
16.3. Company Profiles: Key Players
16.3.1. Teva Pharmaceutical Industries Ltd
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Valeant Pharmaceuticals International, Inc
16.3.3. Sun Pharmaceutical Industries Ltd
16.3.4. Evonik Industries AG
16.3.5. Coating Place, Inc
16.3.6. GlaxoSmithKline plc
16.3.7. Corium International, Inc
16.3.8. Orbis Biosciences, Inc
16.3.9. Mylan N.V
16.3.10. Pfizer, Inc
16.3.11. Evonik
16.3.12. Colorcon
16.3.13. BASF SE
16.3.14. Novartis AG
16.3.15. AstraZeneca
16.3.16. Depomed, Inc

17. Primary Key Insights
  • INQUIRE BEFORE BUYING